ProjectCA209-76K: Efficacy Study of Nivolumab Compared to Placebo in Prevention of Recurrence of MelanomaAfter Complete…

Basic data

Title:
CA209-76K: Efficacy Study of Nivolumab Compared to Placebo in Prevention of Recurrence of MelanomaAfter Complete Resection of Stage IIB/C Melanoma (CheckMate 76K)
Duration:
1/1/2020 to 12/31/2027
Abstract / short description:
A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy with Nivolumab
versus Placebo after Complete Resection of Stage IIB/C Melanoma
(CheckMate 76K: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 76K)
Keywords:
melanoma
Melanom

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Help

will be deleted permanently. This cannot be undone.